Diener on Neurology

• Recent Neurology Data Highlight Treatments to Avoid   Although recent neurology literature brought good news for rituximab in relapsing-remitting multiple sclerosis, the results were decidedly more mixed for other treatments, says Dr Christoph Diener.
  Medscape Neurology, August 25, 2022
• The Role of Aspirin Today   Since first being synthesized in 1897, aspirin has become a staple neurologic treatment. It's time to sign the praises of this humble drug, says Dr Christoph Diener.
  Medscape Neurology, July 28, 2022
• The State of Monoclonal Antibodies for Migraine   Dr Christoph Diener on the enticing efficacy and safety of anti-CGRPs.
  Medscape Neurology, July 15, 2022
• ESOC 2022 A New Treatment of Choice for Basilar Thrombosis   Dr Christoph Diener summarizes the best data from May's European Stroke Organisation Conference.
  Medscape Neurology, June 13, 2022
• Five New Neurology Studies: Possible Breakthroughs, Some Failures   Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.
  Medscape Neurology, May 09, 2022
• Neurology Journal Highlights: 6 New Studies   Dr Christoph Diener on compelling recent data on sleep disorders, MS and pregnancy, ALS, and COVID-19.
  Medscape Neurology, April 18, 2022
• Recent Findings in Neurology: Multiple Sclerosis and Stroke   Dr Christoph Diener discusses recent studies in neurology focused on multiple sclerosis and stroke.
  Medscape Neurology, April 06, 2022
• 2021's Top Neurology Studies   Dr Christoph Diener highlights the data from this past year that you need to know going into 2022.
  Medscape Neurology, January 07, 2022
• Last Month in Neurology Research: Some Ups, Some Downs   Dr Christoph Diener highlights five recently published studies, most of which failed to show a benefit to various interventions.
  Medscape Neurology, December 01, 2021
• 7 New Neurology Studies to Know   Dr Christoph Diener shares the latest data on when to treat MS, the safety of COVID-19 vaccines, the genetic underpinnings of cluster headaches, and other topics.
  Medscape Neurology, November 04, 2021
• Key Takeaways From the Latest Stroke Guidelines   Dr Christoph Diener on six new publications whose recommendations cover topics ranging from blood pressure management to COVID-19 vaccinations.
  Medscape Neurology, October 13, 2021
• Updates in Migraine, Cluster, and Posttraumatic Headache   Dr Christoph Diener on 7 recent studies focusing on headache research.
  Medscape Neurology, August 17, 2021
• New Data Suggest Cause of Post-COVID Vaccine Blood Clots   Dr Christoph Diener's monthly journal review takes a closer look at rare neurologic side effects of COVID vaccines and the latest in epilepsy.
  Medscape Neurology, June 08, 2021
• 4 New Stroke Studies and Guidelines to Know   Dr Christoph Diener on new ESO thrombolysis guidelines and data on carotid stenosis, stroke scales, and mobile stroke units.
  Medscape Neurology, April 16, 2021
• 6 Neurology Updates to Know   Dr Christoph Diener highlights the recent literature, including a promising study from the team behind BioNTech's COVID-19 vaccine.
  Medscape Neurology, March 22, 2021
• 5 Updates in Neurology   Dr Christoph Diener highlights new evidence on subdural hematoma, traumatic brain injury, COVID-19, seizure, and multiple sclerosis.
  Medscape Neurology, January 20, 2021
• A Paradigm Shift for Preventing Stroke in Patients With Diabetes   Dr Christoph Diener on the promising new treatments that are taking aim at the deadly consequences of diabetes.
  Medscape Neurology, November 23, 2020
• A Breakthrough in Parkinson Disease and New Data on Treating Stroke   Dr Christoph Diener on the six recent neurology studies with potential impact on the field.
  Medscape Neurology, July 13, 2020
• LDL and Stroke Prevention: How Low to Go   Dr Christoph Diener reviews a new study looking at cholesterol management in secondary stroke prevention, plus other recent studies in neurology.
  Medscape Neurology, January 28, 2020
• Novel Treatments Are Reshaping Migraine Treatment, Prevention   Dr Christoph Diener on the advantages that ditans, CGRP antagonists, and monoclonal antibodies have over earlier treatments.
  Medscape Neurology, December 24, 2019